Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Cancer Research
|
May 27, 1999
A novel animal model for hemangiomas: inhibition of hemangioma development by the angiogenesis inhibitor TNP-470
S Liekens, E Verbeken, M Vandeputte, et al.
Cancer Research
|
July 4, 1998
Potent inhibition of hemangioma formation in rats by the acyclic nucleoside phosphonate analogue cidofovir
S Liekens, G Andrei, M Vandeputte, et al.
Investigational New Drugs
|
June 5, 2013
2-Aminothiophene-3-carboxylic acid ester derivatives as novel highly selective cytostatic agents
J Balzarini, J Thomas, S Liekens, et al.
Cancer Research
|
June 30, 2001
Inhibition of fibroblast growth factor-2-induced vascular tumor formation by the acyclic nucleoside phosphonate cidofovir
S Liekens, J Neyts, E De Clercq, et al.
Nucleosides & Nucleotides
|
August 5, 1999
Antitumor potential of acyclic nucleoside phosphonates
E De Clercq, G Andrei, J Balzarini, et al.
Current Pharmaceutical Design
|
February 7, 2003
Heparin derivatives as angiogenesis inhibitors
M Presta, D Leali, H Stabile, et al.
Biochemical Pharmacology
|
April 25, 2009
Identification of aspartic acid-203 in human thymidine phosphorylase as an important residue for both catalysis and non-competitive inhibition by the small molecule "crystallization chaperone" 5'-O-tritylinosine (KIN59)
A Bronckaers, L Aguado, A Negri, et al.
Molecular Pharmacology
|
July 1, 1999
Modulation of fibroblast growth factor-2 receptor binding, signaling, and mitogenic activity by heparin-mimicking polysulfonated compounds
S Liekens, D Leali, J Neyts, et al.
Nucleosides, Nucleotides & Nucleic Acids
|
October 27, 2006
Thymidine phosphorylase is noncompetitively inhibited by 5'-O-trityl-inosine (KIN59) and related compounds
S Liekens, J Balzarini, A I Hernández, et al.
FEBS Letters
|
November 20, 1998
7-Deazaxanthine, a novel prototype inhibitor of thymidine phosphorylase
J Balzarini, A E Gamboa, R Esnouf, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Cancer Research
|
May 27, 1999
A novel animal model for hemangiomas: inhibition of hemangioma development by the angiogenesis inhibitor TNP-470
S Liekens, E Verbeken, M Vandeputte, et al.
Cancer Research
|
July 4, 1998
Potent inhibition of hemangioma formation in rats by the acyclic nucleoside phosphonate analogue cidofovir
S Liekens, G Andrei, M Vandeputte, et al.
Investigational New Drugs
|
June 5, 2013
2-Aminothiophene-3-carboxylic acid ester derivatives as novel highly selective cytostatic agents
J Balzarini, J Thomas, S Liekens, et al.
Cancer Research
|
June 30, 2001
Inhibition of fibroblast growth factor-2-induced vascular tumor formation by the acyclic nucleoside phosphonate cidofovir
S Liekens, J Neyts, E De Clercq, et al.
Nucleosides & Nucleotides
|
August 5, 1999
Antitumor potential of acyclic nucleoside phosphonates
E De Clercq, G Andrei, J Balzarini, et al.
Current Pharmaceutical Design
|
February 7, 2003
Heparin derivatives as angiogenesis inhibitors
M Presta, D Leali, H Stabile, et al.
Biochemical Pharmacology
|
April 25, 2009
Identification of aspartic acid-203 in human thymidine phosphorylase as an important residue for both catalysis and non-competitive inhibition by the small molecule "crystallization chaperone" 5'-O-tritylinosine (KIN59)
A Bronckaers, L Aguado, A Negri, et al.
Molecular Pharmacology
|
July 1, 1999
Modulation of fibroblast growth factor-2 receptor binding, signaling, and mitogenic activity by heparin-mimicking polysulfonated compounds
S Liekens, D Leali, J Neyts, et al.
Nucleosides, Nucleotides & Nucleic Acids
|
October 27, 2006
Thymidine phosphorylase is noncompetitively inhibited by 5'-O-trityl-inosine (KIN59) and related compounds
S Liekens, J Balzarini, A I Hernández, et al.
FEBS Letters
|
November 20, 1998
7-Deazaxanthine, a novel prototype inhibitor of thymidine phosphorylase
J Balzarini, A E Gamboa, R Esnouf, et al.
Page
of 3